MiguelAOrtegaMD

PubMed

• 19 citations
  Anti-Mycobacterium tuberculosis agents derived from quinoxaline-2-carbonitrile and quinoxaline-2-carbonitrile 1,4-di-N-oxide.
  Miguel A. Ortega, Yolanda Sainz, M. E. Montoya, Andreés Jaso, Beleén Zarranz, Ignacio Aldana, Antonio Monge> ;Arzneimittel-Forschung. 2011 Dec 26
• 25 citations
  Pyrazolo[3,4-b]quinoxalines. A new class of cyclin-dependent kinases inhibitors.
  Miguel A. Ortega, M. E. Montoya, Belén Zarranz, Andrés Jaso, Ignacio Aldana, Sophie Leclerc, Laurent Meijer, Antonio Monge> ;Bioorganic & Medicinal Chemistry. 2002 Jul 1
• 15 citations
  Antimycobacterial activity of new quinoxaline-2-carbonitrile and quinoxaline-2-carbonitrile 1,4-di-N-oxide derivatives.
  Miguel A. Ortega, M. E. Montoya, Andrés Jaso, Belén Zarranz, I. Tirapu, Ignacio Aldana, Antonio Monge> ;Die Pharmazie. 2001 Mar 1
• Anti-malarial activity of some 7-chloro-2-quinoxalinecarbonitrile-1,4-di-N-oxide derivatives.
  Aldana, I., Ortega, M. A., Jaso, A., Zarranz, B., Oporto, P., Giménez, A., Monge, A., Deharo, E.> ;Pharmazie. 2003 Jan
• Synthesis and antituberculosis activity of some new 2-quinoxalinecarbonitriles.
  Montoya, M. E., Sainz, Y., Ortega, M. A., Lopez De Cerain, A., Monge, A.> ;Farmaco. 1999 Mar 19
• New quinoxalinecarbonitrile 1,4-di-N-oxide derivatives as hypoxic-cytotoxic agents.
  Ortega, M. A., Morancho, M. J., Martínez-Crespo, F. J., Sainz, Y., Montoya, M. E., López de Ceráin, A., Monge, A.> ;Eur J Med Chem. 2000 Jan
• Synthesis and antituberculosis activity of new 2-quinoxalinecarbonitrile 1,4-di-N-oxides.
  Ortega, M. A., Sainz, Y., Montoya, M. E., López De Ceráin, A., Monge, A.> ;Pharmazie. 1999 Jan
• New quinoxaline 1,4-di-N-oxides for treatment of tuberculosis.
  Sainz, Y., Montoya, M. E., Martínez-Crespo, F. J., Ortega, M. A., López de Ceráin, A., Monge, A.> ;Arzneimittelforschung. 1999 Jan
• Benzo[1,2-c]1,2,5-oxadiazole N-oxide derivatives as potential antitrypanosomal drugs. Structure-activity relationships. Part II.
  Aguirre, G., Cerecetto, H., Di Maio, R., González, M., Porcal, W., Seoane, G., Ortega, M. A., Aldana, I., Monge, A., Denicola, A.> ;Arch Pharm (Weinheim). 2002 Jan
• Quinoxaline N,N''-dioxide derivatives and related compounds as growth inhibitors of Trypanosoma cruzi. Structure-activity relationships.
  Aguirre, G., Cerecetto, H., Di Maio, R., González, M., Alfaro, M. E., Jaso, A., Zarranz, B., Ortega, M. A., Aldana, I., Monge-Vega, A.> ;Bioorg Med Chem Lett. 2004 Jul 16
• Join now to see all